Public Notice of the Proposed Establishment of the “Expert Consensus on Radioactive 12?I Seed Implantation for the Treatment of Pulmonary Malignancies Integrating Traditional Chinese and Western Medicine” Project
Public Notice of the Proposed Establishment of the “Expert Consensus on Integrated Chinese and Western Medicine with 12?I Seed Implantation for the Treatment of Pulmonary Malignant Tumors” Project
In accordance with the relevant provisions governing international standards of the Asia-Pacific Health Association, and following a review of the formal requirements of the project application and an evaluation of its justification, the international standard development/revision project entitled “Expert Consensus on Integrated Chinese and Western Medicine with 12?I Seed Implantation for the Treatment of Pulmonary Malignant Tumors” is hereby announced for public review at the project establishment stage.
I. Basic Project Information
|
Project Title |
Expert Consensus on Integrated Chinese and Western Medicine with 12?I Seed Implantation for the Treatment of Pulmonary Malignant Tumors |
|
English Title |
Expert Consensus on Integrated Chinese and Western Medicine with 12?I Seed Implantation for the Treatment of Pulmonary Malignant Tumors |
|
Project Number |
APHA-IS-007-2025 |
|
Project Type |
Development of a New Standard |
|
Standard Level |
APHA International Organization Standard; Branch Standard |
|
Proposing Organizations |
Oncology Branch of the Asia-Pacific Health Association; Committee on Traditional Medicine and Cancer Rehabilitation of the Oncology Branch of the Asia-Pacific Health Association; Committee on Integrated Chinese and Western Medicine for Lung Cancer of the China Anti-Cancer Association |
|
Project Scope |
Applicable to departments of oncology, radiation oncology, interventional medicine, thoracic surgery, medical imaging, traditional Chinese medicine, and rehabilitation in general hospitals at all levels and specialized cancer hospitals across the Asia-Pacific region and China, as well as healthcare professionals involved in radioactive seed implantation and whole-process cancer management. The project focuses on standardizing preoperative assessment, individualized treatment planning, intraoperative implantation and quality control, peri-interventional traditional Chinese medicine interventions based on syndrome differentiation, prevention and management of complications, rehabilitation and follow-up, and multidisciplinary collaboration. |
|
Planned Completion Date |
August 31, 2027 |
II. Rationale for Project Establishment
Patients with pulmonary malignancies have a growing need for minimally invasive treatment, precision care, and whole-process management. However, current clinical practice still lacks unified protocols for preoperative assessment, dosimetric planning, intraoperative quality control, peri-interventional management, management of complications, and interventions integrating traditional Chinese and Western medicine. This project will help improve treatment safety and standardization, alleviate patients’ symptoms, and improve treatment tolerability and quality of life.
III. Main Technical Content
The project is intended for departments of oncology, radiation oncology, interventional medicine, thoracic surgery, medical imaging, traditional Chinese medicine, and rehabilitation in general hospitals at all levels and specialized cancer hospitals across the Asia-Pacific region and China, as well as healthcare professionals participating in radioactive seed implantation and whole-process cancer management. It will focus on standardizing preoperative assessment, individualized treatment planning, intraoperative implantation and quality control, peri-interventional traditional Chinese medicine interventions based on syndrome differentiation, prevention and management of complications, rehabilitation and follow-up, and multidisciplinary collaboration. It aims to establish a unified, scientifically sound, and practical international standard that provides a standardized basis for implementation by relevant healthcare institutions and professionals.
IV. Existing Relevant Standards and Reference Sources
Specifications for the Management of Clinical Application of Radioactive Seed Implantation Technology (2022 Edition); Expert Consensus on CT- and Coplanar Template-Guided Radioactive I Seed Implantation for the Treatment of Lung Cancer (2021 Edition); Expert Consensus on 3D-Printed Coplanar Template-Assisted CT-Guided Radioactive 12?I Seed Implantation (2018 Edition); Expert Consensus on CT-Guided Permanent Interstitial Radioactive 12?I Seed Implantation for the Treatment of Tumors (2017 Edition); American Brachytherapy Society consensus guidelines for thoracic brachytherapy for lung cancer (2016).
V. Project Leadership
|
Proponent |
Qiang Zhang |
|
Project Lead |
Fanming Kong |
VI. Public Review Arrangements
The public review period is from [Public Review Start Date: August 10, 2025] to [Public Review End Date: August 16, 2025]. Any objections should be submitted in writing during this period to the branch email address: oboapha@163.com.
Asia-Pacific Health Association
[Date of Issue: August 10, 2025]
